SOMO-V, SOMOV, ABUS, GE U-SYSTEMS

GE Healthcare announced it has acquired U-Systems Inc., which recently gained U.S. Food and Drug Administration (FDA) clearance for the somo•v Automated Breast Ultrasound System (ABUS). It is the first ultrasound system on the market for breast cancer screening as an adjunct to mammography for asymptomatic women with greater than 50 percent dense breast tissue and no prior breast interventions. Financial terms were not disclosed.

iNtuition, a client-server solution for advanced image management, has been expanded with three new capabilities, including iNtuition Review. iNtuition Review enables iNtuition to support multi-monitor display and multi-modality review and is especially suited to the review of images related to conditions such as cardiac and vascular, and interventional oncology procedures.

At RSNA 2012, Philips Nuclear Medicine is introducing new clinical innovations for its positron emission tomography/computed tomography (PET/CT) systems.

University Health System in San Antonio, Texas, was one of the first health systems in the United States to install Carestream’s new DRX-Revolution Mobile X-ray systems. The new DRX-Revolution systems are part of an order for five Carestream wireless digital radiography (DR) systems to help improve care at University Hospital in the South Texas Medical Center and a new outpatient Clinical Pavilion in downtown San Antonio.

Earlier this year the Pancreatic Cancer Action Network released a report titled, "The Alarming Rise of Pancreatic Cancer Deaths in the United States: Why We Need to Stem the Tide Today," detailing the rising threat of pancreatic cancer. The report reveals the startling observation that based on projections of U.S. population and cancer death rates, pancreatic cancer is anticipated to move from the fourth to the second leading cause of cancer death in the United States by 2020, and possibly as early as 2015.

November 9, 2012 — The team of dosimetrists and physicists at D3 Oncology Solutions (D3), an affiliate of UPMC and UPMC CancerCenter, recently surpassed significant milestones: completing its 30,000th advanced treatment plan and commissioning its 100th linear accelerator.

Toshiba’s advanced radiation dose reduction technology, Adaptive Iterative Dose Reduction 3D (AIDR 3D), is now available on all new Aquilion CT systems, from the 16-detector row Aquilion RXL to the 320-detector row Aquilion ONE. AIDR 3D is Toshiba’s third-generation iterative dose reconstruction software incorporating significant system enhancements by reducing radiation dose compared with conventional scanning. 

For more information: www.medical.toshiba.com

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now